Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
AKYAAkoya Biosciences(AKYA) Zacks Investment Research·2024-05-14 06:36

Akoya Biosciences (AKYA) came out with a quarterly loss of 0.35pershareversustheZacksConsensusEstimateofalossof0.35 per share versus the Zacks Consensus Estimate of a loss of 0.30. This compares to loss of 0.49pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−16.670.49 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -16.67%. A quarter ago, it was expected that this tissue analysis provider would post a loss of 0.27 per share when it actually produced a loss of $0.22, delivering a surprise of 18.52%. Over the last four quarters, th ...